Podofilox

Treatment for Hpv Infection

Typical Dosage: 0.5% solution or gel, applied 2x daily for 3 days, 4 days rest, repeat for 4 cycles

Effectiveness
55%
Safety Score
75%
Clinical Trials
50
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
75
DangerousModerateSafe
Treatment Details
Dosage Range
0.5% solution or gel, applied 2x daily for 3 days, 4 days rest, repeat for 4 cycles
Time to Effect
2-6 weeks
Treatment Duration
Up to 4-6 weeks
Evidence Quality
HIGH
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$800
Monitoring:$200
Side Effect Mgmt:$50
Total Annual:$1,050
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
QALYs Gained
Outcome-Based Costs
Cost per Responder
$1,909
Cost per Remission
$1,909
Comparison vs Cryotherapy
Cost Difference
$-100/year
Less expensive
QALY Difference
0.00 QALYs
Same outcomes
Dominance
No dominance
Prescription Access Economics
Annual Societal Loss per Patient
$753
Cost of prescription-only barriers (visits, time, admin, price premium)
Physician Visit Cost
$187.5/year
Time Cost
$52.5/year
Travel + wait time
Insurance Admin Cost
$30/year
Prior auth, claims
Rx Price
$800/year
Potential OTC Price
$267/year
Estimated if OTC available
Early Treatment Benefit
+0.05 QALYs
From faster OTC access
Risk Assessment
Misuse Risk
LOW
Missed Diagnosis Risk
LOW
Podofilox Outcomes

for Hpv Infection

Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+55%
Remission Rate
+55%
Common Side Effects
Local erythema
+70%
Burning sensation
+60%
Pain
+40%
Erosion
+30%
Itching
+25%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov